基于代谢相关基因表达的浆细胞骨髓瘤预后生存模型
该研究利用Gene Expression Omnibus数据库中1040例浆细胞骨髓瘤患者的临床与RNA数据,通过Lasso Cox回归构建了7基因代谢风险评分,并在训练集和验证集中验证其预测5年生存的效能,联合R-ISS评分可提高预测准确性。
要点
- 7基因代谢风险评分高危及低危组5年生存率分别为62%与85%(p<0.001)。
- 代谢风险评分联合R-ISS使生存预测AUC从0.63提升至0.73(p=0.015)。
- 代谢风险评分在训练集和验证集中均显示稳健的5年生存预测效能。
核心结论
- 代谢风险评分可提高浆细胞骨髓瘤患者的生存预测准确性。
研究设计与样本
- 研究纳入Gene Expression Omnibus数据库中1040例浆细胞骨髓瘤患者的临床、实验室及RNA数据,分为训练集(N=1)和验证集(N=2)。
- 通过Lasso Cox回归分析筛选与生存相关的代谢基因并构建代谢风险评分。
主要发现
- 代谢风险评分的5年生存AUC分别为0.71(95%CI 0.65,0.76)、0.88(0.67,1.00)和0.64(0.57,0.70)。
- 训练集中高风险组(评分>中位数)5年生存率62%(55,68%),低风险组85%(80,90%),p<0.001;验证集结果一致。
- 代谢风险评分联合R-ISS的AUC为0.73(0.66,0.78),优于单独R-ISS的0.63(0.58,0.69),p=0.015。
- 体外浆细胞骨髓瘤细胞系实验验证了模型预测。
关键数值与推荐
- 代谢风险评分基于7个代谢相关基因构建。
- 高风险定义为评分>中位数。
- 联合模型AUC=0.73(0.66,0.78),R-ISS单独AUC=0.63(0.58,0.69),p=0.015。
临床怎么用
- 代谢风险评分可用于浆细胞骨髓瘤患者生存分层,联合R-ISS可提升预测准确性。
局限性
- 研究基于公共数据集回顾性分析,需前瞻性验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Accurate survival prediction of persons with plasma cell myeloma (PCM) is challenging. We interrogated clinical and laboratory co-variates and RNA matrices of 1040 subjects with PCM from public datasets in the Gene Expression Omnibus database in training (N = 1) and validation (N = 2) datasets. Genes regulating plasma cell metabolism correlated with survival were identified and seven used to build a metabolic risk score using Lasso Cox regression analyses. The score had robust predictive performance with 5-year survival area under the curve (AUCs): 0.71 (95% confidence interval, 0.65, 0.76), 0.88 (0.67, 1.00) and 0.64 (0.57, 0.70). Subjects in the high-risk training cohort (score > median) had worse 5-year survival compared with those in the low-risk cohort (62% [55, 68%] vs. 85% [80, 90%]; p < 0.001). This was also so for the validation cohorts. A nomogram combining metabolic risk score with Revised International Staging System (R-ISS) score increased survival prediction from an AUC = 0.63 [0.58, 0.69] to an AUC = 0.73 [0.66, 0.78]; p = 0.015. Modelling predictions were confirmed in in vitro tests with PCM cell lines. Our metabolic risk score increases survival prediction accuracy in PCM.
引用
- Huang HY, Wang Y, Wang WD, et al. A prognostic survival model based on metabolism-related gene expression in plasma cell myeloma. Leukemia. 2021. PMID: 33686197. doi:10.1038/s41375-021-01206-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。